Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
6 Minutes 24 Seconds.docx
1. [From 10$/Pg] 6 Minutes 24 Seconds
[From 10$/Pg] 6 Minutes 24 Seconds This week, you became more familiar with how
COVID-19 affects our bodies and communities. While things may still look bleak, the FDA
has granted emergency use authorization to several vaccines to combat COVID-19. One type
of vaccine that has been developed is an RNA-based vaccine. In this week’s Get to Know a
Scientist assignment, you will learn a little bit about RNA-based vaccines and about Dr.
Kizzmekia Corbett and her contribution to developing Moderna’s COVID-19 vaccine.First,
watch the following video that provides a brief explanation of the mechanism behind
Moderna’s RNA-based COVID-19 vaccine:Video Credit: How does Moderna’s Coronavirus
vaccine work? (Links to an external site.) by The Telegraph (Links to an external site.) |
Duration: 1 minute 34 secondsDr. Kizzmekia Corbett, a viral immunologist, has been
working at the National Institutes of Health (NIH) to better understand viral immune
responses. Dr. Corbett served as the scientific lead for the development of Moderna’s
Coronavirus vaccine as you saw above. In addition to her work at the NIH, Dr. Corbett is
involved with science communication and public engagement to inspire youth in
underserved communities. Dr. Corbett is featured in TIME Magazine’s 2021 TIME 100 Next
List (Links to an external site.), which highlights 100 emerging leaders who are trailblazers
in their field.First, read this article from Nature (Links to an external site.) to learn more
about Dr. Kizzmekia Corbett’s efforts to combat vaccine hesitancy in communities of
color.Next, watch the video below to hear Dr. Corbett describe her work and learn about
how she became the leading scientist on the development of this vaccine:Video Credit: Meet
the scientist on the forefront of COVID-19 vaccine development (Links to an external site.)
by CBS This Morning (Links to an external site.) | Duration: 6 minutes 24 secondsOptional:
Take a look at the phase 3 clinical trial results for the Moderna vaccine (Links to an external
site.). It includes interesting/important information on how the trial was carried out,
participant demographics, and safety analysis (i.e., side effects and adverse
reactions).Assignment DetailsAfter reviewing the videos and articles, write a 300 word or
more reflection with your responses to what you saw. Some topics you might wish to
discuss include but are not limited to:What was the most interesting or most confusing
about the resources you examined?What have you learned about the development of
vaccine trials from these articles?What do these resources tell you about the types of people
that do science?What new questions do you have after reviewing these
resources?GradingTo see how this assignment will be graded, scroll down to view the
grading rubric. If no rubric is visible, click on the three dots in the upper right corner of this
2. page, then click “Show Rubric”. If you’re reviewing this assignment using the Canvas mobile
app, the rubric is included in the Grade tab.
![[From 10$/Pg] 6 Minutes 24 Seconds
[From 10$/Pg] 6 Minutes 24 Seconds This week, you became more familiar with how
COVID-19 affects our bodies and communities. While things may still look bleak, the FDA
has granted emergency use authorization to several vaccines to combat COVID-19. One type
of vaccine that has been developed is an RNA-based vaccine. In this week’s Get to Know a
Scientist assignment, you will learn a little bit about RNA-based vaccines and about Dr.
Kizzmekia Corbett and her contribution to developing Moderna’s COVID-19 vaccine.First,
watch the following video that provides a brief explanation of the mechanism behind
Moderna’s RNA-based COVID-19 vaccine:Video Credit: How does Moderna’s Coronavirus
vaccine work? (Links to an external site.) by The Telegraph (Links to an external site.) |
Duration: 1 minute 34 secondsDr. Kizzmekia Corbett, a viral immunologist, has been
working at the National Institutes of Health (NIH) to better understand viral immune
responses. Dr. Corbett served as the scientific lead for the development of Moderna’s
Coronavirus vaccine as you saw above. In addition to her work at the NIH, Dr. Corbett is
involved with science communication and public engagement to inspire youth in
underserved communities. Dr. Corbett is featured in TIME Magazine’s 2021 TIME 100 Next
List (Links to an external site.), which highlights 100 emerging leaders who are trailblazers
in their field.First, read this article from Nature (Links to an external site.) to learn more
about Dr. Kizzmekia Corbett’s efforts to combat vaccine hesitancy in communities of
color.Next, watch the video below to hear Dr. Corbett describe her work and learn about
how she became the leading scientist on the development of this vaccine:Video Credit: Meet
the scientist on the forefront of COVID-19 vaccine development (Links to an external site.)
by CBS This Morning (Links to an external site.) | Duration: 6 minutes 24 secondsOptional:
Take a look at the phase 3 clinical trial results for the Moderna vaccine (Links to an external
site.). It includes interesting/important information on how the trial was carried out,
participant demographics, and safety analysis (i.e., side effects and adverse
reactions).Assignment DetailsAfter reviewing the videos and articles, write a 300 word or
more reflection with your responses to what you saw. Some topics you might wish to
discuss include but are not limited to:What was the most interesting or most confusing
about the resources you examined?What have you learned about the development of
vaccine trials from these articles?What do these resources tell you about the types of people
that do science?What new questions do you have after reviewing these
resources?GradingTo see how this assignment will be graded, scroll down to view the
grading rubric. If no rubric is visible, click on the three dots in the upper right corner of this](https://image.slidesharecdn.com/6minutes24seconds-230605142305-5d4e0e21/85/6-Minutes-24-Seconds-docx-1-320.jpg)
